You are here

Moderna, Merck will not limit price of virus vaccines to company cost

AB_moderna_220720.jpg
Moderna and Merck & Co on Tuesday told a US Congressional panel that they expect to profit from their coronavirus vaccines once approved, amid concerns the vaccines may not be accessible to all.

[BENGALURU] Moderna and Merck & Co on Tuesday told a US Congressional panel that they expect to profit from their coronavirus vaccines once approved, amid concerns the vaccines may not be accessible to all.

"We will not be selling our vaccine at cost, although it is premature for us...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes